Nuclear bodies are distinct subnuclear structures. The survival of motoneuron (SMN) gene is mutated or deleted in patients with the neurodegenerative disease spinal muscular atrophy (SMA). The gene product SMN is a marker protein for one class of nuclear bodies denoted as nuclear gems. SMN has also been found in Cajal bodies, which co-localize with gems in many cell types. Interestingly, SMA patients display a reduced number of gems. Little is known about the regulation of nuclear body formation and stabilization. We have previously shown that a nuclear isoform of the fibroblast growth factor-2 (FGF-2 23 ) binds directly to SMN. In this study, we analyzed the consequences of FGF-2 23 binding to SMN with regard to nuclear body formation. On a molecular level, we showed that FGF-2 23 competed with Gemin2 (a component of the SMN complex that is necessary for gem stabilization) for binding to SMN. Down-regulation of Gemin2 by siRNA caused destabilization of SMN-positive nuclear bodies. This process is reflected in both cellular and in vivo systems by a negative regulatory function of FGF-2 in nuclear body formation: in HEK293 cells, FGF-2 23 decreased the number of SMN-positive nuclear bodies. The same effect could be observed in motoneurons of FGF-2 transgenic mice. This study demonstrates the functional role of a growth factor in the regulation of structural entities of the nucleus. nuclear organization ͉ nuclear structure ͉ spinal muscular atrophy ͉ survival of motoneuron protein
T
he nucleus of a cell is organized into several distinct substructures, including chromatin, nucleoli, speckles, and different types of nuclear bodies (1, 2) . Larger molecular aggregates in the nucleus are denoted as nuclear bodies (1) . Coiled bodies were discovered as accessory bodies of nucleoli (3) and were later renamed Cajal bodies (4, 5) . Cajal bodies contain the marker protein coilin (6) . Formation of Cajal bodies occurs de novo in a non-hierarchical process (7) . Newly assembled small nuclear ribonucleoprotein (snRNP) particles accumulate in Cajal bodies after their nuclear import (8) . Another type of nuclear body was described as ''gemini of coiled bodies'' or gems. These nuclear foci contain the survival of motoneuron (SMN) protein and its interacting protein Gemin2 (SIP1) (9) . SMN is mutated in patients with spinal muscular atrophy (10) . At least in the cytoplasm, SMN is part of a larger complex containing spliceosomal Sm proteins and a group of proteins designated Gemins 2-8 (11) . SMN and coilin directly interact in Cajal bodies (12) .
Many factors determine the number and morphology of SMN-containing nuclear bodies. Formation of Cajal bodies is dependent on SmB, as up-regulation of this snRNP component leads to the appearance of this nuclear substructure (13) . In a straightforward analysis, it has been shown that phosphorylation of critical residues in the coilin C terminus regulates the number of Cajal bodies (14) . The number of Cajal bodies increases in transformed cells (15) . Also, Cajal bodies and gems display a higher degree of co-localization in later developmental stages (16) . SMN contains a motif encoded by exon 2b that is responsible for targeting to Cajal bodies (17) . In most cell lines, Cajal bodies and gems co-localize (5) , but gems represent a distinct class of nuclear substructures (11, 16, 18) . In motoneurons, SMN-positive foci are more frequent in adult than in fetal stages. The number of SMN-positive foci is correlated with SMA disease severity in fibroblasts from SMA patients (19) . It is still unclear whether the number of gems is directly responsible for disease pathology or is merely indicative of decreased SMN expression levels in SMA patients. Functionally, gems have been suggested to be part of the snRNP recycling machinery (20) .
We have previously shown that a nuclear isoform of fibroblast growth factor-2 (FGF-2 23 ) directly interacts and co-localizes with SMN (21, 22) . FGF-2 belongs to the expanding family of growth factors with intranuclear and intracellular localization in addition to their role as extracellular signaling molecules (23) . This growth factor is expressed as different isoforms that are translated from one mRNA species. The 18 kDa isoform (FGF-2 18 ) is generated after translation initiation at a conventional AUG start codon, whereas upstream alternative CUG start codons are used for expression of the high-molecular weight isoforms (hmw) 21 and 23 kDa FGF-2 (rat FGF-2 21 and FGF-2 23 ). FGF-2 isoforms are differentially regulated during development, after pharmacological treatment, and after nerve injury (24) , indicating different biological roles for the individual isoforms.
In this study, we looked at the molecular and functional consequences of FGF-2 23 /SMN complex formation with regard to Gemin2 binding and nuclear body formation. On a molecular level, we showed that FGF-2 23 competes with Gemin2 in a concentration-dependent manner for binding to SMN. Because interaction between Gemin2 and SMN is important for the stabilization and integrity of gems (25, 26) , we analyzed the formation of SMN-positive nuclear foci after overexpression of FGF-2 23 . In this study, we refer to the nuclear structures labeled by the anti-SMN antibody as ''SMN-positive nuclear bodies/foci'' to highlight the fact that both Cajal bodies and gems are labeled. On a cellular level, the number of gems decreased in HEK293 cells when the intracellular concentration of the FGF-2 23 isoform was increased, whereas Cajal bodies were not affected. Interestingly, in transgenic mice that overexpress FGF-2, the number of gems in motoneurons was similarly decreased. These results demonstrate a function for a nuclear growth factor as a direct modulator of the structural integrity of gems.
bind to nucleic acids in vitro (30) . Previously, we have shown that binding of U2 small nuclear RNA (snRNA) is not affected by FGF-2 23 binding to SMN (22) . Therefore, we asked whether FGF-2 23 is able to compete with Gemin2 for binding to SMN. Full-length human SMN was recombinantly expressed and immobilized on glutathione-agarose beads by a GST tag at its C terminus. Gemin2 was expressed in a coupled in vitro transcription/translation reticulocyte lysate system. As expected, Gemin2 bound to SMN, as shown by a Western blot of the extensively washed beads (Fig. 1A) . Incubation of the complex with increasing amounts of recombinantly expressed and purified FGF-2 23 led to a decrease in the amount of Gemin2 bound to SMN (Fig.  1 A) . A clear reduction of Gemin2 binding (2.5 g in each lane) could be seen with the addition of 10 g of FGF-2 23 . In addition, immunoprecipitation experiments were performed with an anti-SMN antibody in nuclear extracts from cells expressing different amounts of FGF-2 23 (Fig. 1B ). An increased concentration of FGF-2 23 resulted in immunoprecipitation of less Gemin2, which corroborates the result of the pull-down experiments. These data demonstrate competition between FGF-2 23 and Gemin2 for binding to SMN.
Knock-Down of Gemin2 Expression Causes Destabilization of Gems,
but Not Cajal Bodies. The functional consequences of Gemin2 loss with regard to formation of nuclear bodies is unknown. Here, we down-regulated Gemin2 by siRNA transfection of HEK293 cells. Briefly, cells were transfected with a Gemin2-specific siRNA oligonucleotide or a scrambled siRNA that had a sequence with the same purine/pyrimidine base composition. Co-transfections with fluorescein-labeled dsRNA oligomers were performed to ensure that only transfected cells were analyzed in the subsequent counts of nuclear bodies. Three days after transfection, 57.3% Ϯ 8.3% of the cells (n ϭ 3 experiments, n ϭ 2659 cells) still showed fluorescence of the control oligomers. This approach excludes the possibility that the knock-down-efficiency was very high in only a few cells. Down-regulation of Gemin2 protein levels was observed after 48 hours by Western blot (Fig.  2A) . After 72 hours, cells displayed a 44.8% knock-down (Ϯ4.9%, n ϭ 3) of the starting level, confirming successful and significant down-regulation as determined by densitometry (Fig.  2B) . To quantify the number of SMN-positive nuclear bodies, cells were fixed and processed for immunocytochemistry with an anti-SMN antibody. The number of SMN-positive nuclear bodies per cell was counted (n Ͼ 800 cells analyzed) and a frequency distribution was calculated (Fig. 2C ). Few cells displayed three or more SMN-positive nuclear bodies, with most cells showing no or one nuclear body. For statistical evaluation, we compared the overall frequency distributions between the different conditions ( 2 test). At 72 hours after transfection with Gemin2-specific siRNA or scrambled siRNA, a significant change in the frequency distribution between both conditions could be observed (Fig. 2C) . More nuclei lacked SMN-positive nuclear structures when treated with Gemin2 siRNA. These data indicate that Gemin2 regulates the number of SMN-positive nuclear bodies. Its loss at least partially destabilizes these nuclear structures. In contrast, Cajal bodies stained for coilin as a marker protein were not affected by down-regulation of Gemin2 (Fig.  2C) . To determine the fraction of nuclear bodies that are both coilin positive and SMN positive in HEK293 cells, we performed double staining experiments with the appropriate antibodies (Fig. 2D) . Most of the stained endogenous structures were coilin positive, but only half of the Cajal bodies were SMN positive; that is, 50.3% of the structures were SMN positive and 49.7% of these were Cajal bodies. (Fig. 3A) , was counted and plotted as a frequency distribution for all analyzed cells (Fig. 3B) . No change in the frequency distribution between SMN/empty vector and SMN/FGF-2 18 could be observed, as these proteins did not interact. Importantly, cotransfection with FGF-2 23 revealed a significant left shift between the distributions (Fig. 3B ). Cells transfected with FGF-2 23 displayed significantly less SMN-positive nuclear bodies than the empty vector control cells. As an additional control, we transfected cells with a SMN deletion construct lacking the first 27 aa residues (SMN28-294), which contains part of the binding site for FGF-2 23 (22) and the binding site for Gemin2 (29) . Therefore, the lack of this sequence in SMN precludes the binding of . This finding agrees well with quantitative data for SMN-positive nuclear bodies, as some nuclear bodies were still present, even at high FGF-2 concentrations in assays quantifying the numbers of SMN-positive structures (Fig. 3B) . hc, heavy chains of the SMN-antibody used for IP.
both proteins (22, 29) . The comparison between the frequency distribution of cells transfected with the deletion construct/FGF-2 23 and the empty vector control revealed no significant difference ( Fig. 3B) , demonstrating the importance of the SMN N terminus for the interaction between both proteins. A comparison between full-length SMN and the SMN28-294 deletion mutants revealed a significant difference, indicating that the missing part of the Gemin2 binding site is responsible for destabilization of nuclear bodies. However, SMN-positive nuclear bodies can still be found, probably because of dimerization of endogenous SMN with the overexpressed deletion mutant. Dimerization of SMN with the SMN28-294 mutant is not affected because the first self-association domain is encoded by exon 2b (amino acid residues 52-91) (28) and the second domain is in the YG-box region encoded by exon 7 (31) . Concomitant with the overexpression of SMN, the average number of SMNpositive structures increased from the endogenous level of 1.8 No difference from the SMN28 -294/empty vector control was detected. Three independent experiments were performed per condition with the following numbers of measured cells: SMN1-294/empty vector n ϭ 619; SMN1-294/FGF-2 18 , n ϭ 377; SMN1-294/FGF-2 23 , n ϭ 636; SMN28 -294/empty vector, n ϭ 557; SMN28 -294/FGF-2 18 , n ϭ 501; and SMN28 -294/FGF-2 23 , n ϭ 502. Error bars represent standard errors of the means. ***P Ͻ 0.001 ( 2 test). Overexpression of FGF-2 23 was estimated to be at least 10-fold more than that of endogenous per cell to 2.6 per cell, as calculated from the control experiments. Whereas a significant change in the number of SMNpositive foci in FGF-2 23 -overexpressing cells occurred, no such change was found for Cajal bodies (Fig. 3C) . To further characterize the nuclear bodies that form in the presence of FGF-2 23 , we performed high-resolution confocal microscopy [supporting information (SI) Fig. S1 ]. In agreement with our quantitative data (Fig. 3B) , we showed that overexpressed FGF-2 23 localized SMN to nuclear bodies that were not coilin positive (Fig. S1 A, f-h ).
Co-Immunoprecipitation of FGF-2 23 and SMN from Cytoplasmic and
Nuclear Extracts. We performed co-immunoprecipitation experiments to analyze the relative protein levels in nuclear and cytoplasmic extracts in the presence and absence of FLAGtagged FGF-2 23 . HEK293 cells were transiently transfected with FGF-2 23 -3XFLAG or empty control vector. Input as well as immunoprecipitated proteins were analyzed by Western blot analysis using the anti-SMN antibody (Fig. 4) . The same blot was incubated with anti-Histone H3 antibody to demonstrate efficient isolation of nuclear proteins. No change in endogenous or overexpressed SMN levels was detected between the nuclear and cytoplasmic extracts when FGF-2 23 was present (Fig. 4, lanes 6,  8, 14, and 16) . Therefore, FGF-2 23 did not change the partition of SMN between the cytoplasm and the nucleus. Analysis of the same Western blots with anti-FLAG antibody showed coimmunoprecipitation of FGF-2 23 . However, most FGF-2 23 was found in the nuclear extract fraction (Fig. 4, lanes 6, 7, 14 , and 15). Co-expression of SMN-EGFP led to a higher amount of SMN/FGF-2 23 complexes in the cytoplasm (Fig. 4, lane 6 ) compared with non-pSMN-EGFP-transfected cells (Fig. 4, lane  7) . This did not occur in the nuclear fraction (Fig. 4, lanes 14 and  15) , indicating a rate-limiting mechanism for SMN transport into the nucleus, which is independent of SMN expression levels. FGF-2 23 was in part proteolytically degraded to a previously described 16-kDa fragment (32) found in the core sequence that is common to all FGF-2 isoforms (Fig. 4, lanes 2, 3, 10, and 11 ). This fragment did not interact with SMN (Fig. 4, lanes 6, 7, 14 , and 15), as it lacks the arginine-rich N terminus of the FGF-2 23 -isoform.
Transgenic FGF-2 Mice Display a Reduced Number of SMN-Positive
Nuclear Bodies. Overexpression of FGF-2 in transgenic mice (TgFGF-2) should result in a decrease of the number of SMNpositive nuclear bodies, but not Cajal bodies in vivo. To test this hypothesis, we quantified nuclear bodies in motoneurons of spinal cords from TgFGF-2 mice by anti-SMN and anti-coilin immunohistochemistry and compared them with motoneurons from wild-type littermates. These mice overexpress all human isoforms of FGF-2 (18, 22, 23 , and 24 kDa) in all analyzed tissues (33) . Lumbar spinal cords were dissected, rapidly fixed, and processed for immunohistochemistry with anti-SMN antibody. Motoneurons were identified by their topography in the ventral horn of segments L2-L4 and morphologically by their large, multipolar cell bodies (Fig. 5A) . The numbers of SMN-positive nuclear bodies were counted in wild-type mice as well as TgFGF-2 mice. The comparison of the frequency distributions revealed a significant difference between the two, with fewer SMN-positive nuclear bodies in the TgFGF-2 animals (Fig. 5B) ; however, Cajal bodies were not affected (Fig. 5B) . These data confirm the hypothesis that an increased intracellular amount of FGF-2 destabilizes nuclear body formation of specific subnuclear structures.
Discussion
In this study, we showed that intracellular FGF-2 23 negatively regulates the number of SMN-positive nuclear bodies in vitro in HEK293 cells as well as in vivo in adult mouse motoneurons. The results in the cellular and in vivo systems are supported at the molecular level by the finding that FGF-2 23 competes with Gemin2. We have previously shown that FGF-2 23 is in a common complex with SMN and directly interacts with its N terminus, whereas FGF-2 18 is not co-immunoprecipitated by SMN, probably because of the lack of the RG-rich N terminus present in the higher molecular weight FGF-2 isoform (21). FGF-2 23 is able to bind directly to a sequence within the first 90 aa residues of SMN (21, 22) . This sequence encoded by exons 1-3 of the SMN gene has been described as a binding site for nucleic acids and Gemin2. We previously demonstrated that U2 small nuclear RNA and FGF-2 23 do not compete for binding to SMN (22) . Therefore, we explored whether FGF-2 23 competes with Gemin2 for binding to SMN. As predicted by the overlapping binding domains of FGF-2 23 and Gemin2 on SMN, increasing amounts of FGF-2 23 displaced Gemin2 as shown in an in vitro binding assay and by co-immunoprecipitation. This finding confirms a competitive mode of interaction with SMN. Formation of gems is dependent on co-expression of SMN and Gemin2 (34) . Moreover, depletion of SMN by siRNA leads to a concomitant down-regulation of Gemin2 and a complete destabilization of gems in HeLa cells (25) . However, a reciprocal effect on SMN expression by down-regulation of Gemin2 was not observed (25) . With regard to coilin, depletion of SMN by siRNA causes coilin (lanes 6, 7) , indicating an interaction between SMN and FGF-2 23 mainly in the nucleus. FGF-2 23 was partly proteolytically degraded to a known 16-kDa fragment (32) , which can be seen in the input (lanes 2, 3, 10, and 11), but did not interact with SMN because of the lack of the SMN-interaction domain. lc, light chains of of the SMN-antibody used for IP; hc, heavy chains of the SMN-antibody used for IP.
to localize in multiple nuclear foci instead of in Cajal bodies (35, 36) and to partly disperse into the nucleolus (36) . In this study, we performed a knock-down of Gemin2 in HEK293 cells and analyzed the formation of SMN-positive foci. A quantitative evaluation revealed a significant decrease in the average number of SMN-positive foci; however, complete destabilization was not observed, in agreement with previously published data (25) . Gemin2 knock-down did not affect the number of Cajal bodies; whereas knock-down of SMN caused a significant decrease in the number of Cajal bodies (37) . Gemin2 had a more subtle, but clearly visible, effect on nuclear body formation upon downregulation. In agreement with these data, overexpression of FGF-2 23 in vitro and in vivo led to a decrease in gems but not Cajal bodies. This effect was not observed with the noninteracting isoform FGF-2 18 , which confirms the specific effect of FGF-2 23 .
The functional context of FGF-2 23 -binding to SMN was also evaluated. Although the number of gems is significantly reduced in motoneurons of FGF-2 transgenic mice, no SMA-like phenotype developed in the 3-month-old animals used for these analyses. These data indicate that the number or structural integrity of gems may not be directly relevant to SMA disease progression. Instead, other nuclear or axonal SMN functions could be responsible for motor neuron degeneration (38) (39) (40) (41) (42) (43) (44) . Furthermore, only a subset of SMN molecules is bound by FGF-2 23 (21, 22) . This finding does not exclude the possibility that FGF-2 23 modulates splicing and snRNP formation by binding to SMN, thereby defining a subclass of snRNPs with distinct properties. A FGF-2 23 -dependent decrease of gems could influence a putative function of SMN in snRNP-recycling. In this scenario, two possibilities for FGF-2 activity exist: first, FGF-2 is translated and immediately transported to the nucleus; second, exogenous FGF-2 is internalized upon binding to the extracellular portion of FGF-tyrosine kinase receptors and is transported to the nucleus. In this way, FGF-2 23 interacts with two proteins in the splicing pathway, namely SMN and the 66-kDa subunit of splicing factor SF3a (21, 45) , which is a component of U2 snRNPs (46) . The growth factor FGF-2 may act as an intracellular modulator of splicing, allowing cell-signalingdependent regulation of splicing events. Interestingly, FGFreceptor 1 (FGFR1) is also a nuclear protein (47) and the central molecule of a cascade named integrative nuclear FGFR1 signaling (INFS) (48) . This pathway leads to shuttling of FGFR1 to the nucleus and feeding forward of signals to the transcriptional coactivator CREB-binding protein, thereby up-regulating gene activities associated, for example, with differentiation and development of neuronal cells (48) . Moreover, nuclear FGFR1 localizes to nuclear speckles containing snRNPs (49) and the splicing factor SC35 (50). FGF-2 23 -but, surprisingly, not FGF-2 18 -binds to nuclear FGFR1 and regulates its nuclear mobility (51) . These data argue for the possibility that FGFR1 could act in RNA metabolism. It is an interesting question as to whether FGF-2 23 could be a structural or functional link between nuclear FGFR1 signaling and SMN activities: SMN could be a regulator of the INFS pathway, thereby exerting effects on, for example, neuronal differentiation.
In conclusion, we have demonstrated that a nuclear growth factor is able to regulate the number of SMN-positive nuclear foci. Besides gems and Cajal bodies, several types of nuclear bodies exist in cells; however, only a few factors are known to be important for their structure, formation, or number. These results further our knowledge about the regulatory processes that determine the number of SMN-containing nuclear bodies.
Methods
Plasmids. Full-length human SMN pSMN1-294-EGFP and the mutants pSMN1-239-EGFP and pSMN235-294-EGFP were described before (43) . For expression of Gemin2, a complete cDNA contained in pCMV-SPORT6 was used. For co-expression experiments, untagged and DsRed2 (Invitrogen)-tagged FGF-2 23 and FGF-2 18 were used as described previously (21) . FLAG-tagged FGF-2 23 was constructed by cloning FGF-2 23 cDNA into the EcoRI/HindIII sites of p3XFLAG-CMV-14 (Sigma), resulting in clone pFGF-2 23 -3XFLAG. The SMNdeletion mutant pSMN119 -294-EGFP, comprising amino acid residues 119 -294, was cloned by polymerase chain reaction (PCR) into the EcoRl/Sall sites of pEGFP-N2 (Clontech). The cDNA of coilin was reverse transcription-PCR cloned in frame within the NheI/HindIII sites of pEGFP-N1 (Clontech), resulting in the pCoilin-EGFP plasmid. The plasmid GFP-mCoilin⌬RG (12) was a generous gift of G. Matera (University of North Carolina at Chapel Hill, NC).
Competition Assay. Recombinant SMN protein was expressed in E. coli using the pET System (Novagene), as described previously, and then purified and immobilized on glutathione agarose (22) . Gemin2 was synthesized in vitro by use of the SP6-TnT-Quick (Promega) coupled Transcription/Translation System. Proteins were analyzed and quantified by Coomassie staining after sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). FGF-2 was purified as described earlier (22), but with the modification of using the E. coli strain BL21 DE3-trx. A constant amount of Ϸ1 g SMN protein bound to glutathione beads was used for the competition experiments. Beads were blocked for 30 minutes at 4°C in 1 ml IP-buffer 300 (20 mmol/l Tris/HCl, pH 7.5, 300 mmol/l NaCl, 2 mmol/l EDTA, 25 mmol/l ␤-glycerophosphate, 1 mmol/l sodium orthovanadate, 1% Triton X-100, 1% sodium deoxycholate, and 1ϫ wild-type, n ϭ 3 animals, n ϭ 288 cells; transgenic FGF-2 mice, n ϭ 3 animals, n ϭ 382 cells). The frequencies of cells with a certain number of nuclear bodies were plotted. Error bars represent standard errors of the means. **P Ͻ 0.01 ( 2 test); n.s., non-significant.
Complete protease inhibitor (Roche) supplemented with 1% [wt/vol] bovine serum albumin [BSA] ). Gemin2 protein (2.5 g) was added to each competition reaction as well as increasing amounts of recombinant FGF-2 23 . IP-buffer 300 was added to a total reaction volume of 300 l. The reactions were incubated for 2 hours at 4°C and subsequently washed three times with 1 ml IP-buffer 300 and two times with 1 ml phosphate-buffered saline (PBS) followed by Western blot analysis as previously described (21) . The primary antibodies anti-FGF-2 (BD Biosciences) and anti-Gemin2 (Abcam) were used for Western blotting.
Additional methods are described in SI Text.
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Colorview II (Olympus). Confocal microscopy was performed on a Leica TCS SP2, equipped with Leica acquisition software, using oil immersion objective HCX PL APO BL (ϫ63/numeric aperture 1.4). Images were assembled with Adobe Photoshop (Adobe).
Statistical Analysis. For nuclear body counting, frequency distributions were calculated with Excel 2003 (Microsoft Corporation). Significance differences between distributions were evaluated by the 2 test using this program. Other statistical calculations (arithmetic means, standard errors, and significance) were performed with GraphPad Prism 4 (GraphPad Software). Bar graphs were also created with GraphPad Prism 4. Statistical differences between arithmetic means (Fig. 2B) were evaluated with the Mann-Whitney test. 
